Diagnosis of Sleep-Related Respiratory Disorders in Patients With Narcotic Medications

Completed · Not applicable

Conditions studied: Narcotic Use, Central Sleep Apnea

In brief

The present study is a prospective, single cohort study involving patients on narcotic medications, undergoing overnight sleep studies in the clinical sleep laboratory. The main hypothesis for the study is that the the frequency of sleep respiratory events (including central apneas) identified by a home sleep apnea test (HSAT) device (WatchPAT200U (wp200U) with centrals; Itamar Medical Ltd.) will significantly correlate with in-lab polysomnography (gold standard).

Key facts

Study ID

NCT03670914

Run by

Kaiser Permanente

People needed

24

Starts

2019-08-08

Expected to finish

2025-03-13

Last updated by the study team

2026-07-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Kaiser Permanente member
• Patient is able to read, understand and sign the informed consent form.
• Subject on current narcotic prescription with of at least 4 nights/week (subject will be asked on night of PSG if they took narcotic medication and specific medication taken)

You may not qualify if…

• Finger deformity that precludes adequate sensor appliance
• Use of one of the following medications: alpha blockers, short acting nitrates (less than 3 hours before the study)
• Patients that are oxygen dependent
• Patients with Chronic Obstructive Pulmonary Disease (COPD) with FEV1 <70%, obesity hypoventilation syndrome, neuromuscular weakness

Where it is running

• Sleep Center; San Bernardino County Medical Center, Kaiser Permanente — Fontana, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.